Literature DB >> 7049370

Pharmacology of cyclophosphamide and metabolites.

M Colvin, J Hilton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7049370

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  25 in total

1.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

2.  The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.

Authors:  M D Bacolod; S M Lin; S P Johnson; N S Bullock; M Colvin; D D Bigner; H S Friedman
Journal:  Curr Cancer Drug Targets       Date:  2008-05       Impact factor: 3.428

Review 3.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

4.  Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.

Authors:  K Scott Baker; Kirsten K Ness; Julia Steinberger; Andrea Carter; Liton Francisco; Linda J Burns; Charles Sklar; Stephen Forman; Daniel Weisdorf; James G Gurney; Smita Bhatia
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

5.  In vitro synergism of 4-hydroperoxycyclophosphamide and cisplatin: relevance for bone marrow purging.

Authors:  R H Peters; C S Brandon; L A Avila; O M Colvin; R K Stuart
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients.

Authors:  Carmen Balańa; Cristina Carrato; José Luis Ramírez; Andrés Felipe Cardona; Mireia Berdiel; José Javier Sánchez; Miquel Tarón; Cristina Hostalot; Eva Musulen; Aurelio Ariza; Rafael Rosell
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

7.  Autologous bone marrow transplantation for acute leukemia using transplant chemopurified with metabolite of oxazaphosphorines (ASTA Z 7557, INN mafosfamide). First clinical results.

Authors:  P Hervé; J Y Cahn; E Plouvier; M Flesch; E Tamayo; R Leconte des Floris; A Peters
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

8.  Carbon tetrachloride-induced increase in the antitumor activity of cyclophosphamide in mice: a pharmacokinetic study.

Authors:  R N Harris; P J Basseches; P L Appel; A M Durski; G Powis
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 9.  Long-term consequences of hematopoietic stem cell transplantation: current state of the science.

Authors:  K Scott Baker; Saro Armenian; Smita Bhatia
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-24       Impact factor: 5.742

10.  Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.

Authors:  Q Dong; N Bullock; F Ali-Osman; O M Colvin; D D Bigner; H S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.